Molecular Mechanisms of Chromosome Dynamics

My laboratory aims to understand how chromosomal inheritance is achieved with such fidelity in mammalian cells. We study the genetic and epigenetic mechanisms that control the faithful transmission of our genetic material.
Specifically, we are interested in centromeres, key chromosomal loci required for cell division. We aim to identify: i) how centromeres are established, ii) the mechanisms that govern centromere function, iii) how their integrity is maintained during the cell cycle and iv) the role that centromere failure plays in genome instability.
We use molecular and cell biological approaches combined with genetics, physics and biochemistry.
Twitter: @FachinettiLab











-
-
-
-
CENP-A chromatin prevents replication stress at centromeres to avoid structural aneuploidyProceedings of the National Academy of Sciences
-
-
-
Phosphorylation of CENP-A on serine 7 does not control centromere functionNature Communications
-
-
UNDERSTAND THE ARCHITECTURE AND ORGANIZATION OF CENTROMERESConducted at the Institut Curie, Daniele Fachinetti's team's work, Molecular Mechanisms of Chromosome Dynamics, represents a significant advance in our understanding of the basic architecture and molecular organization of human centromeres.22/03/2022
-
Deciphering centromeres to understand how cancer cells developCentromeres are, in most of the cases in humans, the center of our chromosomes and play an essential role in the conservation of our genetic makeup during cell division. Changes to this process can cause cell transformation and, ultimately, can allow cancer to develop.03/03/2021

Daniele was born in Milan, Italy where he carried out his PhD in the laboratory of Marco Foiani (IFOM). Here, he identified for the first time the sites where DNA replication termination occurs and the molecular pathways that control this process (Fachinetti et al., 2010). The study of replication fragile zones sparked his interest in centromeres, which led to his move in 2010 to the laboratory of Don W. Cleveland at the Ludwig Institute in the University of California, San Diego (UCSD). As a post-doc, he characterized a system for rapid protein degradation in human cells (Holland, Fachinetti et al., 2012) and, by combining genome-editing techniques, he answered two long-standing questions in the genetics field: the nature of the epigenetic mark of centromeres (Fachinetti et al., 2013; Fachinetti et al., 2017) and the contribution of centromeric DNA sequence in centromere function (Fachinetti et al., 2015).
He then started as a junior group leader at the department of “Cell biology and cancer” at the Institut Curie supported by the ATIP-AVENIR program in 2016, and became a CNRS member in 2016. He obtained prestigious awards such as the Emergences program from the City of Paris and the EMBO young investigator program (YIP), and in 2021 he was promoted to director of research of the CNRS (DR2).
-
Post-doctorat en biologie cellulaire (H/F)Le Centre de recherche de l’Institut Curie
L'Institut Curie est un acteur majeur de la recherche et de la lutte contre le cancer. Il est constitué d'un hôpital et d'un Centre de recherche de plus de 1000 collaborateurs avec une forte représentativité internationale.
L’objectif du Centre de recherche de l’institut Curie est de développer la recherche fondamentale et d’utiliser les connaissances produites pour améliorer le diagnostic, le pronostic, la thérapeutique des cancers dans le cadre du continuum entre la recherche fondamentale et l’innovation au service du malade.
-
Postdoctoral Position in Cell Biology (M/F)Institut Curie Research Center
Institut Curie is a major player in the research and fight against cancer. It consists of a Hospital group and a Research Center of more than 1000 employees with a strong international representativeness. The objective of the Research Center is to develop basic research and to use the knowledge produced to improve the diagnosis, prognosis, and therapeutics of cancers as part of the continuum between basic research and innovation serving the patient.